388 related articles for article (PubMed ID: 28385608)
1. Comparison of the nine polymorphic membrane proteins of Chlamydia trachomatis for their ability to induce protective immune responses in mice against a C. muridarum challenge.
Pal S; Favaroni A; Tifrea DF; Hanisch PT; Luczak SET; Hegemann JH; de la Maza LM
Vaccine; 2017 May; 35(19):2543-2549. PubMed ID: 28385608
[TBL] [Abstract][Full Text] [Related]
2. The cationic liposomal adjuvants CAF01 and CAF09 formulated with the major outer membrane protein elicit robust protection in mice against a Chlamydia muridarum respiratory challenge.
Pal S; Tifrea DF; Follmann F; Andersen P; de la Maza LM
Vaccine; 2017 Mar; 35(13):1705-1711. PubMed ID: 28238632
[TBL] [Abstract][Full Text] [Related]
3. Vaccination with the recombinant major outer membrane protein elicits antibodies to the constant domains and induces cross-serovar protection against intranasal challenge with Chlamydia trachomatis.
Tifrea DF; Ralli-Jain P; Pal S; de la Maza LM
Infect Immun; 2013 May; 81(5):1741-50. PubMed ID: 23478318
[TBL] [Abstract][Full Text] [Related]
4. A vaccine formulated with the major outer membrane protein can protect C3H/HeN, a highly susceptible strain of mice, from a Chlamydia muridarum genital challenge.
Pal S; Tatarenkova OV; de la Maza LM
Immunology; 2015 Nov; 146(3):432-43. PubMed ID: 26423798
[TBL] [Abstract][Full Text] [Related]
5. Protection against an intranasal challenge by vaccines formulated with native and recombinant preparations of the Chlamydia trachomatis major outer membrane protein.
Sun G; Pal S; Weiland J; Peterson EM; de la Maza LM
Vaccine; 2009 Aug; 27(36):5020-5. PubMed ID: 19446590
[TBL] [Abstract][Full Text] [Related]
6. Immunization with the Chlamydia trachomatis mouse pneumonitis major outer membrane protein by use of CpG oligodeoxynucleotides as an adjuvant induces a protective immune response against an intranasal chlamydial challenge.
Pal S; Davis HL; Peterson EM; de la Maza LM
Infect Immun; 2002 Sep; 70(9):4812-7. PubMed ID: 12183524
[TBL] [Abstract][Full Text] [Related]
7. Comparison of intranasal and transcutaneous immunization for induction of protective immunity against Chlamydia muridarum respiratory tract infection.
Skelding KA; Hickey DK; Horvat JC; Bao S; Roberts KG; Finnie JM; Hansbro PM; Beagley KW
Vaccine; 2006 Jan; 24(3):355-66. PubMed ID: 16153755
[TBL] [Abstract][Full Text] [Related]
8. A vaccine formulated with a combination of TLR-2 and TLR-9 adjuvants and the recombinant major outer membrane protein elicits a robust immune response and significant protection against a Chlamydia muridarum challenge.
Cheng C; Pal S; Tifrea D; Jia Z; de la Maza LM
Microbes Infect; 2014 Mar; 16(3):244-52. PubMed ID: 24291713
[TBL] [Abstract][Full Text] [Related]
9. Vaccination with the polymorphic membrane protein A reduces Chlamydia muridarum induced genital tract pathology.
Müller T; Becker E; Stallmann S; Waldhuber A; Römmler-Dreher F; Albrecht S; Mohr F; Hegemann JH; Miethke T
Vaccine; 2017 May; 35(21):2801-2810. PubMed ID: 28413133
[TBL] [Abstract][Full Text] [Related]
10. Outer membrane proteins preferentially load MHC class II peptides: implications for a Chlamydia trachomatis T cell vaccine.
Karunakaran KP; Yu H; Jiang X; Chan Q; Moon KM; Foster LJ; Brunham RC
Vaccine; 2015 Apr; 33(18):2159-66. PubMed ID: 25738816
[TBL] [Abstract][Full Text] [Related]
11. Computational modeling of TC0583 as a putative component of the Chlamydia muridarum V-type ATP synthase complex and assessment of its protective capabilities as a vaccine antigen.
Tifrea DF; Barta ML; Pal S; Hefty PS; de la Maza LM
Microbes Infect; 2016 Apr; 18(4):245-53. PubMed ID: 26706820
[TBL] [Abstract][Full Text] [Related]
12. Immunization with the Chlamydia trachomatis major outer membrane protein, using adjuvants developed for human vaccines, can induce partial protection in a mouse model against a genital challenge.
Pal S; Peterson EM; Rappuoli R; Ratti G; de la Maza LM
Vaccine; 2006 Feb; 24(6):766-75. PubMed ID: 16199110
[TBL] [Abstract][Full Text] [Related]
13. Co-delivery of amphipol-conjugated adjuvant with antigen, and adjuvant combinations, enhance immune protection elicited by a membrane protein-based vaccine against a mucosal challenge with Chlamydia.
Tifrea DF; Pal S; Le Bon C; Giusti F; Popot JL; Cocco MJ; Zoonens M; de la Maza LM
Vaccine; 2018 Oct; 36(45):6640-6649. PubMed ID: 30293763
[TBL] [Abstract][Full Text] [Related]
14. Induction of cross-serovar protection against genital chlamydial infection by a targeted multisubunit vaccination approach.
Li W; Guentzel MN; Seshu J; Zhong G; Murthy AK; Arulanandam BP
Clin Vaccine Immunol; 2007 Dec; 14(12):1537-44. PubMed ID: 17942608
[TBL] [Abstract][Full Text] [Related]
15. Intranasal vaccination with Chlamydia pneumoniae induces cross-species immunity against genital Chlamydia muridarum challenge in mice.
Manam S; Chaganty BK; Evani SJ; Zafiratos MT; Ramasubramanian AK; Arulanandam BP; Murthy AK
PLoS One; 2013; 8(5):e64917. PubMed ID: 23741420
[TBL] [Abstract][Full Text] [Related]
16. Immunization with an acellular vaccine consisting of the outer membrane complex of Chlamydia trachomatis induces protection against a genital challenge.
Pal S; Theodor I; Peterson EM; de la Maza LM
Infect Immun; 1997 Aug; 65(8):3361-9. PubMed ID: 9234798
[TBL] [Abstract][Full Text] [Related]
17. Induction of protection against vaginal shedding and infertility by a recombinant Chlamydia vaccine.
Carmichael JR; Pal S; Tifrea D; de la Maza LM
Vaccine; 2011 Jul; 29(32):5276-83. PubMed ID: 21609745
[TBL] [Abstract][Full Text] [Related]
18. Vaccination with major outer membrane protein proteosomes elicits protection in mice against a Chlamydia respiratory challenge.
Tifrea DF; Pal S; Toussi DN; Massari P; de la Maza LM
Microbes Infect; 2013 Nov; 15(13):920-7. PubMed ID: 23999313
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of a multisubunit recombinant polymorphic membrane protein and major outer membrane protein T cell vaccine against Chlamydia muridarum genital infection in three strains of mice.
Yu H; Karunakaran KP; Jiang X; Brunham RC
Vaccine; 2014 Aug; 32(36):4672-80. PubMed ID: 24992718
[TBL] [Abstract][Full Text] [Related]
20. Chlamydial polymorphic membrane proteins: regulation, function and potential vaccine candidates.
Vasilevsky S; Stojanov M; Greub G; Baud D
Virulence; 2016; 7(1):11-22. PubMed ID: 26580416
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
